A Study of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage

NCT05126407 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 87

Last updated 2023-02-01

No results posted yet for this study

Summary

The purpose of this study is to proactively collect customer feedback on the performance aspects and risk factors of Olynth Nasal Saline Drops/Spray and Olynth Ectomed Nasal Spray.

Conditions

Sponsors & Collaborators

  • Johnson & Johnson Consumer Inc. (J&JCI)

    lead INDUSTRY

Principal Investigators

  • Akash Pandhare, MD. Ph.D. · Johnson & Johnson Consumer Inc. (J&JCI)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-17
Primary Completion
2022-01-20
Completion
2022-01-20

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05126407 on ClinicalTrials.gov